Literature DB >> 11055357

Optimising inhibitors of trypanothione reductase using solid-phase chemistry.

B Chitkul1, M Bradley.   

Abstract

A series of inhibitors of the enzyme trypanothione reductase has been identified using directed solid-phase chemistry. The compounds were based on a series of polyamine scaffolds and used the natural product kukoamine A as the lead structure. A compound with a Ki of 76 nM was identified, although somewhat surprisingly the compound appeared to be noncompetitive in nature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055357     DOI: 10.1016/s0960-894x(00)00471-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Parasite-specific trypanothione reductase as a drug target molecule.

Authors:  R Luise Krauth-Siegel; Oliver Inhoff
Journal:  Parasitol Res       Date:  2003-04-23       Impact factor: 2.289

2.  Identification of a new endogenous metabolite and the characterization of its protein interactions through an immobilization approach.

Authors:  Jarosław Kalisiak; Sunia A Trauger; Ewa Kalisiak; Hirotoshi Morita; Valery V Fokin; Mike W W Adams; K Barry Sharpless; Gary Siuzdak
Journal:  J Am Chem Soc       Date:  2009-01-14       Impact factor: 15.419

3.  Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.

Authors:  Ahilan Saravanamuthu; Tim J Vickers; Charles S Bond; Mark R Peterson; William N Hunter; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

4.  Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.

Authors:  Daniel Spinks; Emma J Shanks; Laura A T Cleghorn; Stuart McElroy; Deuan Jones; Daniel James; Alan H Fairlamb; Julie A Frearson; Paul G Wyatt; Ian H Gilbert
Journal:  ChemMedChem       Date:  2009-12       Impact factor: 3.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.